Evidence map›Paper›PMID 26589902›Full record

ArticleClinical journal of gastroenterology2015

A case of inflammatory hepatocellular adenoma displaying an unusual histological pattern.

Hiroaki Kanda, Reiko Furuta, Noriko Motoi, Tomoyo Kakita, Yoshiya Sugiura, Toshiyuki Unno, Kiyoshi Matsueda, Akio Saiura, Masahiko Sugitani, Yuichi Ishikawa

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hiroaki KandaDepartment of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR) and Clinicopathology Center, The Cancer Institute Hospital of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. hkanda-ind@umin.ac.jp.
Reiko FurutaDepartment of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR) and Clinicopathology Center, The Cancer Institute Hospital of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Noriko MotoiDepartment of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR) and Clinicopathology Center, The Cancer Institute Hospital of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Tomoyo KakitaDepartment of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR) and Clinicopathology Center, The Cancer Institute Hospital of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Yoshiya SugiuraDepartment of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR) and Clinicopathology Center, The Cancer Institute Hospital of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Toshiyuki UnnoDepartment of Radiology, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
Kiyoshi MatsuedaDepartment of Radiology, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
Akio SaiuraDepartment of Surgery, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
Masahiko SugitaniDepartment of Pathology, School of Medicine, Nihon University, 30-1 Ohyaguchi-Kamichou, Itabashi-ku, Tokyo, 173-8610, Japan.
Yuichi IshikawaDepartment of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR) and Clinicopathology Center, The Cancer Institute Hospital of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
The Cancer Institute Hospital · JPJapanese Foundation For Cancer Research · JPNihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular adenoma (HCA) is a rare type of liver tumor. Here, we report a variant case of HCA in a 56-year-old Japanese man which displayed unusual histological features. The patient had undergone surgery for esophageal and gastric cancer 2 years prior. A computed tomography scan performed in the follow-up period detected a single lesion (diameter 1.4 cm) in the right posterior lobe of the liver, leading to a partial hepatectomy. Histologically, the lesion was composed of two different types of cells. The larger cells, which accounted for most of the cells in the tumor, exhibited granular and eosinophilic cytoplasm, large nuclei and apparent nucleoli. These cells, which were designated the common cells, were typical of the HCA. The other cells, which were designated the pyknotic cells, were smaller, possessed an eosinophilic, homogeneous cytoplasm and pyknotic small nuclei, but did not contain nucleoli. Immunohistochemically, the common cells reacted strongly positive for C-reactive protein and serum amyloid A, which is compatible with a diagnosis of inflammatory HCA; in contrast, the pyknotic cells tested negative for these molecules. Since the pyknotic cells tested positive for several markers of apoptosis, they were considered to be apoptotic. In addition, as the common cells demonstrated a higher ki-67 labeling index, the lesion was considered to display upregulated cell kinetics, i.e. increases in both cell growth and death. Although HCA is a rare type of tumor, there have been several reports on HCA variants. The case reported here is that of a new type of HCA variant that demonstrated an unusual histological pattern and upregulated cell kinetics.

Indexed as

Adenoma, Liver CellC-Reactive ProteinHepatectomyHumansImmunohistochemistryInflammationKi-67 AntigenLiver NeoplasmsMaleMiddle AgedSerum Amyloid A ProteinC-Reactive ProteinKi-67 AntigenSerum Amyloid A ProteinApoptosisHepatocellular adenomaHistology

Identifiers

PMID26589902
OpenAlexW2180340009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.